CaRe Clinic Joins hyperCORE International to Strengthen Global Clinical Research Capabilities

The clinical research industry sees significant advancement as CaRe Clinic, a prominent multi-specialty research organization based in Alberta, Canada, joins the collaborative super network of hyperCORE International. This strategic alliance represents a notable expansion of hyperCORE's global reach and capabilities in conducting clinical trials across multiple therapeutic areas. The partnership brings together CaRe Clinic's two state-of-the-art research centers serving Calgary and Red Deer with hyperCORE's established international network, creating enhanced opportunities for medical research collaboration.

CaRe Clinic contributes substantial resources to the partnership, including access to a potential patient pool of over 1.8 million individuals through investigators' databases and strong partnerships with affiliated clinics. This extensive patient database, combined with the organization's community-centric recruitment strategy, provides unparalleled participant recruitment capabilities across various medical indications. The clinic has demonstrated expertise across multiple medical fields, having participated in hundreds of clinical trials in women's health, dermatology, general medicine, vaccines, infectious diseases, and migraine treatments.

Troy Hamilton, Director of Operations at CaRe Clinic, emphasized the partnership's significance for global research collaboration. The inclusion of CaRe Clinic into hyperCORE International's network substantially strengthens the organization's presence in Canada with multiple locations and multi-therapeutic offerings. hyperCORE International, already an industry leader in providing Phase I-IV clinical trial services, now expands its global footprint to span two continents and five countries with more than 120 active research sites.

Carlos Orantes, President of hyperCORE and CEO at alliance partner Alcanza Clinical Research, expressed enthusiasm about the collaboration's immediate impact on their Canadian operations. The partnership leverages hyperCORE's decades of clinical research experience, with alliance partners having completed more than 7,000 studies and evaluated thousands of new drugs and treatments in over 150,000 randomized patients. The organization maintains strong commitment to research excellence, prioritizing subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention throughout all clinical trials.

This collaboration addresses critical challenges in clinical research, particularly in patient recruitment and retention, by combining CaRe Clinic's robust patient database with hyperCORE's extensive experience and global network. The partnership is expected to accelerate clinical research and drug development timelines, potentially leading to faster medical breakthroughs across therapeutic areas. For the broader medical and pharmaceutical industries, this alliance represents the growing trend toward integrated, efficient, and globally connected clinical research networks that emphasize international cooperation in advancing medical science.

As clinical research continues to evolve, partnerships between organizations like CaRe Clinic and hyperCORE International play increasingly crucial roles in shaping medical research and drug development futures. The collaboration demonstrates how strategic alliances can enhance research capabilities while maintaining focus on patient benefits and healthcare system improvements worldwide. The combined strengths of both organizations create new opportunities for addressing complex medical challenges through shared expertise and expanded research infrastructure.